Dr. Olivier Clément, PhD, and Dr. Pierre-Henri Lefevre[email protected]Clinical NewsGadolinium chelates for MRI: Where are we now?The safety of MRI contrast agents came under close scrutiny at the Journées Francophones de Radiologie congress. Dr. Olivier Clément, PhD, from Paris and Dr. Pierre-Henri Lefevre from Nîmes provided timely summaries of the current and future status of these products and asked what the literature tells us.October 17, 2016Page 1 of 1Top StoriesCTSOLACE+ project to support lung cancer screening in 19 countriesThe project aims to implement low-dose CT (LDCT) lung cancer screening programs.Radiology EducationFrom research to inclusion at RRF 2026 in LondonWomens ImagingCEM improves margin extent measurement, falls short of primary outcomeNuclear MedicineZurich symposium examines 25 years of PET/CT and its futureSponsor ContentFREE webinar: find your imaging capacity